This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $4,950.00, is a fixed-price delivery order to provide the Arthrex ACP Double Syringe System, an innovative orthopedic medical product. The contract has an ultimate completion date of October 21, 2024.
Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company specializes in developing and manufacturing a comprehensive range of advanced orthopedic technologies, surgical implants, instruments, and biologics for government healthcare systems, particularly the Department of Veterans Affairs (VA) and the Department of Defense (DoD). This contract award is not designated as a set-aside contract, indicating Arthrex's strong competitive position in the open federal market.
In addition to this delivery order, Arthrex holds a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders, further demonstrating the company's ability to efficiently support government healthcare systems with specialized orthopedic solutions.
Generated 1/15/25, 9:03 AM